{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T14:47:30Z","timestamp":1783003650144,"version":"3.54.5"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s11910-021-01144-9","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T14:17:18Z","timestamp":1633357038000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Management of Intracerebral Hemorrhage: Update and Future Therapies"],"prefix":"10.1007","volume":"21","author":[{"given":"Howard","family":"Kirshner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Schrag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,2]]},"reference":[{"key":"1144_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S1474-4422(09)70025-0","volume":"8","author":"VL Feigin","year":"2009","unstructured":"Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009;8:355\u201369.","journal-title":"Lancet Neurol"},{"issue":"4","key":"1144_CR2","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1742-1241.2008.01708.x","volume":"62","author":"HS Kirshner","year":"2008","unstructured":"Kirshner HS. Medical management of intracerebral hemorrhage: back to the basics. Int J Clin Pract. 2008;62(4):521\u20132.","journal-title":"Int J Clin Pract"},{"key":"1144_CR3","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Schrag M, Kirshner H. Management of intracerebral hemorrhage: JACC Focus Seminar. J Am Coll Cardiol .2020. 75:1819\u201331. This is a more comprehensive review of ICH","DOI":"10.1016\/j.jacc.2019.10.066"},{"key":"1144_CR4","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1161\/01.STR.0000160756.72109.95","volume":"36","author":"ML Flaherty","year":"2005","unstructured":"Flaherty ML, Woo D, Haverbusch M, et al. Racial variations in location and risk of intracerebral hemorrhage. Stroke. 2005;36:934\u20137.","journal-title":"Stroke"},{"key":"1144_CR5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/neup.12089","volume":"34","author":"JA Dye","year":"2014","unstructured":"Dye JA, Rees G, Yang I, Vespa PM, Martin NA, Vinters HV. Neuropathologic analysis of hematomas evacuated from patients with spontaneous intracerebral hemorrhage. Neuropathology. 2014;34:253\u201360.","journal-title":"Neuropathology"},{"issue":"14","key":"1144_CR6","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1212\/WNL.0b013e3182143317","volume":"76","author":"D Dowlatshahi","year":"2011","unstructured":"Dowlatshahi D, Demchuk AM, Flaherty ML, Ali M, Lyden PL, Smith EE. Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes. Neurology. 2011;76(14):1238\u201344.","journal-title":"Neurology"},{"issue":"2","key":"1144_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1161\/01.STR.18.2.311","volume":"18","author":"HV Vinters","year":"1987","unstructured":"Vinters HV. Cerebral amyloid angiopathy: a critical review. Stroke. 1987;18(2):311\u201324.","journal-title":"Stroke"},{"issue":"2","key":"1144_CR8","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/ana.410380219","volume":"38","author":"SM Greenberg","year":"1995","unstructured":"Greenberg SM, Rebeck GW, Vonsattel JPG, et al. Apolipoprotein E \u03b54 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol. 1995;38(2):254\u20139.","journal-title":"Ann Neurol"},{"issue":"7","key":"1144_CR9","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.03.041","volume":"25","author":"T Doden","year":"2016","unstructured":"Doden T, Sato H, Sasahara E, et al. Clinico-radiological characteristics and pathological diagnosis of cerebral amyloid angiopathy-related intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2016;25(7):1736\u201345.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"3","key":"1144_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00401-009-0615-z","volume":"119","author":"M Schrag","year":"2010","unstructured":"Schrag M, McAuley G, Pomakian J, et al. Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study. Acta Neuropathol. 2010;119(3):291\u2013302.","journal-title":"Acta Neuropathol"},{"key":"1144_CR11","doi-asserted-by":"crossref","unstructured":"\u2022 Greenberg SM, Charidimou A. Diagnosis of cerebral amyloid angiopathy: evolution of the Boston criteria. Stroke. 2018. 49(2):491\u2013497. Definitive article on criteria for diagnosis of CAA","DOI":"10.1161\/STROKEAHA.117.016990"},{"issue":"8","key":"1144_CR12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s11910-016-0674-1","volume":"16","author":"M Schrag","year":"2016","unstructured":"Schrag M, Kirshner H. Neuropsychological effects of cerebral amyloid angiopathy. Curr Neurol Neurosci Reports. 2016;16(8):76.","journal-title":"Curr Neurol Neurosci Reports"},{"key":"1144_CR13","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1212\/WNL.35.7.943","volume":"35","author":"CS Kase","year":"1985","unstructured":"Kase CS, Robinson RK, Stein RW, et al. Anticoagulant-related intracerebral hemorrhage. Neurology. 1985;35:943\u20138.","journal-title":"Neurology"},{"issue":"10","key":"1144_CR14","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.07.006","volume":"23","author":"M Schrag","year":"2014","unstructured":"Schrag M, Greer D. Clinical associations of cerebral microbleeds on magnetic resonance neuroimaging. J Stroke Cerebrovasc Dis. 2014;23(10):2489\u201397.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1144_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000452718","volume":"43","author":"A Malhotra","year":"2017","unstructured":"Malhotra A, Schindler J, MacGrory B, et al. Cerebral microhemorrhages and meningeal siderosis in infective endocarditis. Cerebrovasc Dis. 2017;43:59\u201367.","journal-title":"Cerebrovasc Dis"},{"key":"1144_CR16","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1161\/STROKEAHA.110.609479","volume":"42","author":"I Wagner","year":"2011","unstructured":"Wagner I, Hauer E, Staykov D, et al. Effects of continuous hypertonic saline infusion on peri-hemorrhagic edema evolution. Stroke. 2011;42:1540\u20135.","journal-title":"Stroke"},{"key":"1144_CR17","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1161\/STR.0000000000000069","volume":"46","author":"JC Hemphill","year":"2015","unstructured":"Hemphill JC, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2015;46:2032\u201360.","journal-title":"Stroke"},{"issue":"4","key":"1144_CR18","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1161\/01.STR.0000259633.59404.f3","volume":"38","author":"R Wada","year":"2007","unstructured":"Wada R, Aviv RI, Fox AJ, et al. CT angiography \u201cspot sign\u201d predicts hematoma expansion in acute intracerebral hemorrhage. Stroke. 2007;38(4):1257\u201362.","journal-title":"Stroke"},{"key":"1144_CR19","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1056\/NEJM198705143162001","volume":"316","author":"N Poungvarin","year":"1987","unstructured":"Poungvarin N, Bhoopat W, Viriyavejakul A, et al. Effects of dexamethasone in primary supratentorial intracerebral hemorrhage. New Engl J Med. 1987;316:1229\u201333.","journal-title":"New Engl J Med"},{"key":"1144_CR20","first-page":"439","volume":"19","author":"GBD 2016 Stroke Collaborators","year":"2019","unstructured":"GBD 2016 Stroke Collaborators. Global, regional, and national burden of stroke, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;19:439\u201358.","journal-title":"Lancet Neurol"},{"key":"1144_CR21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/00005053-196501000-00004","volume":"140","author":"CM Fisher","year":"1965","unstructured":"Fisher CM, Picard EH, Polak A, et al. Acute hypertensive cerebellar hemorrhage: diagnosis and surgical treatment. J Nerv Ment Dis. 1965;140:38\u201357.","journal-title":"J Nerv Ment Dis"},{"key":"1144_CR22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1001\/archneur.1974.00490390042003","volume":"31","author":"KH Ott","year":"1974","unstructured":"Ott KH, Kase CS, Ojemann RG, Mohr JP. Cerebellar hemorrhage: diagnosis and treatment. A review of 56 cases. Arch Neurol. 1974;31:160\u20137.","journal-title":"Arch Neurol"},{"key":"1144_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0140-6736(61)90353-1","volume":"278","author":"W McKissock","year":"1961","unstructured":"McKissock W, Richardson A, Taylor J. Primary intracerebral haemorrhage: a controlled trial for surgical and conservative treatment in 180 unselected cases. Lancet. 1961;278:221\u20136.","journal-title":"Lancet"},{"key":"1144_CR24","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3171\/jns.1989.70.4.0530","volume":"70","author":"LM Auer","year":"1989","unstructured":"Auer LM, Deinsberger W, Niederkorn K, et al. Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: a randomized study. J Neurosurg. 1989;70:530\u20135.","journal-title":"J Neurosurg"},{"issue":"5","key":"1144_CR25","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3171\/jns.1989.70.5.0755","volume":"70","author":"S Juvela","year":"1989","unstructured":"Juvela S, Heiskanen O, Poranen A, et al. The treatment of spontaneous intracerebral hemorrhage: a prospective randomized trial of surgical and conservative treatment. J Neurosurg. 1989;70(5):755\u20138.","journal-title":"J Neurosurg"},{"key":"1144_CR26","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0140-6736(05)70233-6","volume":"365","author":"AD Mendelow","year":"2005","unstructured":"Mendelow AD, Gregson BA, Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomized trial. Lancet. 2005;365:387\u201397.","journal-title":"Lancet"},{"key":"1144_CR27","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(13)60986-1","volume":"382","author":"AD Mendelow","year":"2013","unstructured":"Mendelow AD, Gregson BA, Rowan EN, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICHII): a randomized trial. Lancet. 2013;382:397\u2013408.","journal-title":"Lancet"},{"issue":"12","key":"1144_CR28","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1161\/STROKEAHA.109.559948","volume":"40","author":"AM Naidech","year":"2009","unstructured":"Naidech AM, Garg RK, Liebling S, et al. Anticonvulsant use and outcomes after intracerebral hemorrhage. Stroke. 2009;40(12):3810\u20135.","journal-title":"Stroke"},{"key":"1144_CR29","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1161\/STROKEAHA.116.012410","volume":"47","author":"E Gilmore","year":"2016","unstructured":"Gilmore E, Maciel C, Hirsch L, Sheth K. Review of the utility of prophylactic anticonvulsant use in critically ill patients with intracerebral hemorrhage. Stroke. 2016;47:2666\u201372.","journal-title":"Stroke"},{"issue":"2","key":"1144_CR30","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/00003246-199602000-00022","volume":"24","author":"C Tietjen","year":"1996","unstructured":"Tietjen C, Hurn P, Ulatowski JA, Kirsch J. Treatment modalities for hypertensive patients with intracranial pathology: options and risks. Crit Care Med. 1996;24(2):311\u201322.","journal-title":"Crit Care Med"},{"key":"1144_CR31","doi-asserted-by":"crossref","unstructured":"\u2022 Anderson CS, Heeley E, Huang Y, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. New England Journal of Medicine. 2013. 368:2355\u20132365. This is a critical study on blood pressure lowering for ICH","DOI":"10.1056\/NEJMoa1214609"},{"key":"1144_CR32","doi-asserted-by":"crossref","unstructured":"\u2022 Qureshi A, Palesch Y, Barsan W, et al. Intensive blood pressure lowering in patients with acute cerebral hemorrhage. New England Journal of Medicine. 2016. 375:1033\u20131043. Another pivotal study on blood pressure lowering","DOI":"10.1056\/NEJMoa1603460"},{"issue":"9","key":"1144_CR33","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S1474-4422(19)30196-6","volume":"18","author":"TJ Moullaali","year":"2019","unstructured":"Moullaali TJ, Wang X, Martin RH, et al. Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data. Lancet Neurol. 2019;18(9):857\u201364.","journal-title":"Lancet Neurol"},{"issue":"3","key":"1144_CR34","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1385\/NCC:4:3:206","volume":"4","author":"S Mayer","year":"2006","unstructured":"Mayer S, Brun N, Broderick J, et al. Recombinant activated factor VII for acute intracerebral hemorrhage: US phase IIA trial. Neurocrit Care. 2006;4(3):206\u201314.","journal-title":"Neurocrit Care"},{"key":"1144_CR35","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1056\/NEJMoa0707534","volume":"358","author":"SA Mayer","year":"2008","unstructured":"Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated Factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358:2127\u201337.","journal-title":"N Engl J Med"},{"key":"1144_CR36","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s10140-016-1464-4","volume":"24","author":"R Rehmani","year":"2017","unstructured":"Rehmani R, Han A, Hassan J, Farkas J. Role of prothrombin complex concentrate (PCC) in acute intracerebral hemorrhage with positive CTA spot sign: An institutional experience at a regional and state designated stroke center. Emerg Radiol. 2017;24:241\u20137.","journal-title":"Emerg Radiol"},{"key":"1144_CR37","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1161\/STROKEAHA.117.017591","volume":"48","author":"S Poli","year":"2017","unstructured":"Poli S, Hartig F, Selim MH, et al. Prothrombin complex concentrates use in intracerebral hemorrhage. Stroke. 2017;48:2644\u20136.","journal-title":"Stroke"},{"key":"1144_CR38","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/ana.25134","volume":"83","author":"ST Gerner","year":"2018","unstructured":"Gerner ST, Kuramatsu JB, Sembill JA, et al. Association of prothrombin complex concentrate administration and hematoma enlargement in non-vitamin K antagonist oral anticoagulant-related intracerebral hemorrhage. Ann Neurol. 2018;83:186\u201396.","journal-title":"Ann Neurol"},{"key":"1144_CR39","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1056\/NEJMoa1707278","volume":"377","author":"CV Pollack","year":"2017","unstructured":"Pollack CV, Reilly PA, van Ryn J, et al. Idarucizumab for dabigatran reversal-Full cohort analysis. N Engl J Med. 2017;377:431\u201341.","journal-title":"N Engl J Med"},{"issue":"14","key":"1144_CR40","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1056\/NEJMoa1814051","volume":"380","author":"SJ Connolly","year":"2019","unstructured":"Connolly SJ, Crowther M, Eikelboom JW. Full study report of Andexanet Alfa for bleeding associated with Factor Xa inhibitors. N Engl J Med. 2019;380(14):1326\u201335.","journal-title":"N Engl J Med"},{"issue":"10038","key":"1144_CR41","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1016\/S0140-6736(16)30392-0","volume":"387","author":"MI Baharoglu","year":"2016","unstructured":"Baharoglu MI, Cordonnier C, Salman RA, et al. Platelet transfusions versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomized, open-label, phase 3 trial. Lancet. 2016;387(10038):2605\u201313.","journal-title":"Lancet"},{"issue":"1","key":"1144_CR42","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3171\/2012.9.JNS112286","volume":"118","author":"X Li","year":"2013","unstructured":"Li X, Sun Z, Zhao W, et al. Effect of acetylcaslicylic acid usage and platelet transfusion on postoperative hemorrhage and activities of daily living in patients with acute intracerebral hemorrhage. J Neurosurg. 2013;118(1):94\u2013103.","journal-title":"J Neurosurg"},{"issue":"3","key":"1144_CR43","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/ncpneph0421","volume":"3","author":"S Hedges","year":"2007","unstructured":"Hedges S, Dehoney SB, Hooper JS, Amanzadeh J, Busti A. Evidence based treatment recommendations for uremic bleeding. Nat Clin Pract Nephrol. 2007;3(3):138\u201353.","journal-title":"Nat Clin Pract Nephrol"},{"key":"1144_CR44","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1056\/NEJM198301063080102","volume":"308","author":"M Mannucci","year":"1983","unstructured":"Mannucci M, Remuzzi G, Pusineri F, et al. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med. 1983;308:8\u201312.","journal-title":"N Engl J Med"},{"key":"1144_CR45","first-page":"e343","volume":"48","author":"S Yaghi","year":"2017","unstructured":"Yaghi S, Willey JZ, Cucchiara B, et al. Treatment and outcomes of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke. Stroke. 2017;48:e343\u201361.","journal-title":"Stroke"},{"issue":"2","key":"1144_CR46","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s12028-013-9861-y","volume":"19","author":"SD Yeatts","year":"2013","unstructured":"Yeatts SD, Palesch YY, Moy CS, Selim M. High dose deferoxamine in intracerebral hemorrhage (HI-DEF) trial: rationale, design, and methods. Neurocrit Care. 2013;19(2):257\u201366.","journal-title":"Neurocrit Care"},{"issue":"5","key":"1144_CR47","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S1474-4422(19)30069-9","volume":"18","author":"M Selim","year":"2019","unstructured":"Selim M, Foster L, Moy C, et al. Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomized, placebo-controlled, double-blind phase 2 trial. Lancet Neurol. 2019;18(5):428\u201338.","journal-title":"Lancet Neurol"},{"key":"1144_CR48","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-021-01208-1","author":"D Greer","year":"2021","unstructured":"Greer D, Ritter J, Helbok R, Badjatia N, Ko S-B, Guanci M, Sheth K. Impact of Fever Prevention in Brain-Injured Patients (INTREPID): study protocol for a randomized controlled trial. Neurocrit Care. 2021. https:\/\/doi.org\/10.1007\/s12028-021-01208-1.","journal-title":"Neurocrit Care"},{"key":"1144_CR49","unstructured":"\u2022 Hanley DF, Thompson RE, Rosenblum M, et al. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIEIII): a randomized, controlled, open-label, blinded endpoint phase 3 trial. Lancet. 2019. 393(10175):1021\u20131032. Pivotal study on placement of a catheter into the hemorrhage cavity"},{"issue":"4","key":"1144_CR50","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1227\/NEU.0000000000001316","volume":"80","author":"MA Labib","year":"2017","unstructured":"Labib MA, Shah M, Kassam AB, et al. The safety and feasibility of image-guided BrainPath-mediated transsulcal hematoma evacuation: a multicenter study. Neurosurgery. 2017;80(4):515\u201324.","journal-title":"Neurosurgery"},{"issue":"1","key":"1144_CR51","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1227\/NEU.0000000000001258","volume":"13","author":"AM Bauer","year":"2017","unstructured":"Bauer AM, Rasmussen PA, Bain MD. Initial single-center technical experience with the BrainPath system for acute intracerebral hemorrhage evacuation. Oper Neurosurg (Hagerstown). 2017;13(1):69\u201376.","journal-title":"Oper Neurosurg (Hagerstown)"},{"issue":"3","key":"1144_CR52","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/00003246-200103000-00031","volume":"29","author":"MN Diringer","year":"2011","unstructured":"Diringer MN, Edwards DF. Admission to a neurologic\/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med. 2011;29(3):635\u201340.","journal-title":"Crit Care Med"},{"key":"1144_CR53","first-page":"217","volume":"15","author":"MJ Pfleger","year":"1994","unstructured":"Pfleger MJ, Hardee EP, Contant CF, Hayman AL. Sensitivity and specificity of fluid-blood levels for coagulopathy in acute intracerebral hematomas. AJNR Am J Neuroradiol. 1994;15:217\u201323.","journal-title":"AJNR Am J Neuroradiol"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-021-01144-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-021-01144-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-021-01144-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T09:27:50Z","timestamp":1635931670000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-021-01144-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":53,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1144"],"URL":"https:\/\/doi.org\/10.1007\/s11910-021-01144-9","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"28 July 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Howard Kirshner and Matthew Schrag each declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"57"}}